These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30306278)

  • 1. Management of Overactive Bladder Symptoms After Radical Prostatectomy.
    Peyronnet B; Brucker BM
    Curr Urol Rep; 2018 Oct; 19(12):95. PubMed ID: 30306278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Drugs Work for ΟΑΒ Following Prostate Cancer Surgery.
    Sakalis V; Gkotsi A
    Curr Drug Targets; 2020; 21(15):1515-1526. PubMed ID: 32674729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T; Dökmeci F; Çetinkaya ŞE
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects.
    Hsiao SM; Liao SC; Chen CH; Chang TC; Lin HH
    Maturitas; 2014 Dec; 79(4):428-34. PubMed ID: 25238744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy.
    Matsukawa Y; Yoshino Y; Ishida S; Fujita T; Majima T; Funahashi Y; Sassa N; Kato M; Gotoh M
    Neurourol Urodyn; 2018 Aug; 37(6):2008-2014. PubMed ID: 29635709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
    Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
    BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
    Kosilov K; Loparev S; Ivanovskaya M; Kosilova L
    Aging Male; 2015 Mar; 18(1):44-8. PubMed ID: 25136746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects.
    Hsiao SM; Su TC; Chen CH; Chang TC; Lin HH
    Maturitas; 2014 Sep; 79(1):65-9. PubMed ID: 25022469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of refractory OAB in the non-neurogenic patient.
    Wadie BS
    Curr Urol Rep; 2014 Sep; 15(9):438. PubMed ID: 25015301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actual treatment of overactive bladder and urge urinary incontinence.
    Cornu JN
    Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery.
    Lee HY; Kuo HC
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of idiopathic overactive bladder and the success of treatment: a systematic review from ICI-RS 2013.
    Hanna-Mitchell AT; Kashyap M; Chan WV; Andersson KE; Tannenbaum C
    Neurourol Urodyn; 2014 Jun; 33(5):611-7. PubMed ID: 24844598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions.
    Sicras-Mainar A; Navarro-Artieda R; Ruiz-Torrejón A; Sáez-Zafra M; Coll-de Tuero G
    Clin Drug Investig; 2015 Dec; 35(12):795-805. PubMed ID: 26464261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders.
    Liu HT; Chen CY; Kuo HC
    J Formos Med Assoc; 2010 Dec; 109(12):862-78. PubMed ID: 21195884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of health care resources and associated costs in non-institutionalized vulnerable elders with overactive bladder treated with antimuscarinic agents in the usual medical practice.
    Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Aguado-Jodar A; Ruíz-Torrejón A
    Actas Urol Esp; 2014 Oct; 38(8):530-7. PubMed ID: 24630426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.